In our emerging world of web-based health offerings and Net-informed patients, it looks like the name-game is still heating up. Recently I sounded off about whether we should be referred to now as patients or consumers, and don’t forget the term “ePatients” — along with eHeath Consumers, Cybercitizens, etc., etc.
Now Manhattan Research, a highly respected pharmaceutical and healthcare market research firm, has invented a new buzz-term for consumers who use the Internet to research…
Read more »
By
AmyT on
February 19, 2009
Following quickly on my post about Pharma companies warming up to social media, I got a call this week from some folks I know at Sanofi-Aventis. They are launching their very own YouTube channel to promote their Go-Insulin campaign aimed at offsetting the myths and misperceptions about insulin use among type 2 diabetics.
So far, there are seven videos posted — all patients’ personal stories — three of them featuring Gregg Pfaff, the deli owner…
Read more »
By
AmyT on
December 4, 2008
Now this is interesting: I just learned that a new campaign has been launched today called “Cure CVS” — critiquing the nation’s largest retail pharmacy chain for these offenses:
“CVS has repeatedly kept expired drugs on its shelves,
failed to protect sensitive patient data,
overcharged customers in a number of cities,
and stands by corporate policy that puts patient health at risk, which is simply unacceptable.
Numerous racial and income-based issues are also part of…
Read more »
By
AmyT on
August 27, 2008
I noticed that Dr. Alan Rubin’s recent Guest Post here at The Mine stirred up some heated discussion over conflict of interest (COI) — an issue that seems to lurk behind every corner in the business of health and medicine.
When is it OK to be sponsored by pharma company? And when is it OK to trash them, even as they produce the medicines and devices that keep us alive?
I’m no authority on this complex…
Read more »
